Clincosm LogoSign in Get a demo

Stage IIIA Breast Cancer

Showing 51 - 75 of 128
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer Survivor, Healthy Subject, Stage I Colorectal Cancer Trial in Madison (Educational Intervention, Internet-Based

Completed
  • Cancer Survivor
  • +15 more
  • Educational Intervention
  • +4 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Nov 14, 2019

Ductal Breast Carcinoma in Situ, Lobular Breast Carcinoma in Situ, Male Breast Cancer Trial in Winston-Salem (omega-3 fatty

Completed
Has Results
  • Ductal Breast Carcinoma in Situ
  • +8 more
  • omega-3 fatty acid
  • +2 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Oct 7, 2019

Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer Trial in

Completed
Has Results
  • Estrogen Receptor-negative Breast Cancer
  • +7 more
  • Bethesda, Maryland
  • +2 more
Oct 7, 2019

Cancer Survivor, Central Obesity, Estrogen Receptor Positive Trial in Los Angeles (Exercise Intervention, Informational

Withdrawn
  • Cancer Survivor
  • +14 more
  • Exercise Intervention
  • +4 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Oct 21, 2019

Chemotherapeutic Agent Toxicity, Pain, Peripheral Neuropathy Trial in Chicago (cryotherapy, questionnaire administration,

Terminated
  • Chemotherapeutic Agent Toxicity
  • +11 more
  • cryotherapy
  • +4 more
  • Chicago, Illinois
    Northwestern University
Aug 16, 2019

Inflammatory Breast Cancer, Male Breast Cancer, Stage II Breast Cancer Trial in United States (drug, biological, procedure,

Completed
Has Results
  • Inflammatory Breast Cancer
  • +5 more
  • sunitinib malate
  • +7 more
  • Anchorage, Alaska
  • +6 more
Jul 23, 2019

Chemotherapy on Intestinal Bacteria in Newly Diagnosed Breast

Completed
  • Ductal Breast Carcinoma In Situ
  • +5 more
  • Cytology Specimen Collection Procedure
  • +2 more
  • Los Angeles, California
    USC Norris Comprehensive Cancer Center
Jun 17, 2019

Stage I Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer Trial in Los Angeles (other, procedure, behavioral)

Completed
  • Stage I Breast Cancer
  • +4 more
  • questionnaire administration
  • +3 more
  • Los Angeles, California
    USC Norris Comprehensive Cancer Center
Jun 17, 2019

Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer Trial in Chicago (eribulin mesylate,

Unknown status
  • Estrogen Receptor-negative Breast Cancer
  • +10 more
  • eribulin mesylate
  • +2 more
  • Chicago, Illinois
    Northwestern University
Jun 6, 2019

Advanced Malignant Tumor, Cervical Squamous Cell Carcinoma, Endometrial Carcinoma Trial in Scottsdale, Rochester (Laboratory

Completed
  • Advanced Malignant Neoplasm
  • +31 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
  • +1 more
Jun 5, 2019

Sleep Disorder, Stage IA Breast Cancer, Stage IB Breast Cancer Trial in United States (Brief Behavioral Therapy, Telephone-Based

Completed
Has Results
  • Sleep Disorder
  • +6 more
  • Brief Behavioral Therapy
  • +2 more
  • Stanford, California
  • +5 more
Jun 3, 2019

MRI and Cardio-Pulmonary Exercise Testing in Evaluating Exercise

Completed
  • Healthy Subject
  • +7 more
  • Cardiopulmonary Exercise Testing
  • Magnetic Resonance Imaging
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Apr 25, 2019

Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer Trial in Cleveland (trastuzumab, Pertuzumab,

Completed
Has Results
  • Stage II Breast Cancer
  • +3 more
  • trastuzumab
  • +7 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Feb 14, 2019

Male Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer Trial in Houston (biological, drug, procedure, other)

Terminated
Has Results
  • Male Breast Cancer
  • +4 more
  • oblimersen sodium
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 8, 2019

Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer Trial in Winston-Salem (other, behavioral, procedure)

Completed
  • Stage IA Breast Cancer
  • +6 more
  • educational intervention
  • +4 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Jan 23, 2019

HER2/Neu Positive, Stage IA Breast Cancer, Stage IB Breast Cancer Trial in Puerto Rico, United States (drug, other, procedure,

Completed
Has Results
  • HER2/Neu Positive
  • +4 more
  • Mobile, Alabama
  • +114 more
Jan 3, 2019

B-Cell Tumor, Estrogen Receptor Negative, HER2/Neu Negative Trial in Stanford (18F-FSPG, 18F-FDG)

Completed
Has Results
  • B-Cell Neoplasm
  • +15 more
  • Stanford, California
    Stanford University Medical Center
Dec 11, 2018

HER2-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer Trial in Omaha (drug, biological, other)

Terminated
Has Results
  • HER2-negative Breast Cancer
  • +4 more
  • doxorubicin hydrochloride
  • +6 more
  • Omaha, Nebraska
    UNMC Eppley Cancer Center at the University of Nebraska Medical
Dec 10, 2018

Male Breast Cancer, Recurrent Breast Cancer, Stage IIIA Breast Cancer Trial in Seattle (biological, other, genetic)

Completed
Has Results
  • Male Breast Cancer
  • +5 more
  • ONTAK
  • +5 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Nov 9, 2018

HER2-positive Breast Cancer, Male Breast Cancer, Stage II Breast Cancer Trial in Rochester (HER-2/neu peptide vaccine,

Completed
  • HER2-positive Breast Cancer
  • +5 more
  • HER-2/neu peptide vaccine
  • laboratory biomarker analysis
  • Rochester, Minnesota
    Mayo Clinic
Oct 4, 2018

Ductal Carcinoma in Situ, Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-positive Breast Cancer Trial in

Completed
Has Results
  • Ductal Carcinoma in Situ
  • +7 more
  • Baltimore, Maryland
    Johns Hopkins University
Aug 14, 2018

Male Breast Cancer, Recurrent Breast Cancer, Stage IIIA Breast Cancer Trial in Chicago, Evanston (mifepristone, ,

Completed
  • Male Breast Cancer
  • +5 more
  • Chicago, Illinois
  • +1 more
Sep 10, 2018

Stage II Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer Trial in Columbus (Best Practice, Exercise

Unknown status
  • Stage II Breast Cancer
  • +6 more
  • Best Practice
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 7, 2018

Cardiovascular Complications, Recurrent Breast Cancer, Stage I Breast Cancer Trial in Winston-Salem (drug, other, procedure)

Terminated
  • Cardiovascular Complications
  • +7 more
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jul 30, 2018

Estrogen Receptor-positive Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Male Breast Cancer Trial

Terminated
Has Results
  • Estrogen Receptor-positive Breast Cancer
  • +6 more
  • Tucson, Arizona
    Arizona Cancer Center
Jul 23, 2018